105 related articles for article (PubMed ID: 8352006)
1. Optimal conditions of chemotherapeutic sensitivity in K562 cell line using tetrazolium dye assay.
Yu D; Yu LL
Zhongguo Yao Li Xue Bao; 1993 Mar; 14(2):137-40. PubMed ID: 8352006
[TBL] [Abstract][Full Text] [Related]
2. Assay of anticancer drugs in tissue culture: comparison of a tetrazolium-based assay and a protein binding dye assay in short-term cultures derived from human malignant glioma.
Haselsberger K; Peterson DC; Thomas DG; Darling JL
Anticancer Drugs; 1996 May; 7(3):331-8. PubMed ID: 8792008
[TBL] [Abstract][Full Text] [Related]
3. Test for chemotherapeutic sensitivity of cerebral gliomas: use of colorimetric MTT assay.
Jordan JP; Hand CM; Markowitz RS; Black P
J Neurooncol; 1992 Sep; 14(1):19-35. PubMed ID: 1335043
[TBL] [Abstract][Full Text] [Related]
4. Effects of the pH dependence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay.
Plumb JA; Milroy R; Kaye SB
Cancer Res; 1989 Aug; 49(16):4435-40. PubMed ID: 2743332
[TBL] [Abstract][Full Text] [Related]
5. Assessment of antineoplastic agents by MTT assay: partial underestimation of antiproliferative properties.
Sobottka SB; Berger MR
Cancer Chemother Pharmacol; 1992; 30(5):385-93. PubMed ID: 1505077
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a rapid tetrazolium-based colorimetric assay for selecting anticancer drugs.
Chen CF; Hwang JM; Wu CH; Chen CS; Chen KY
Zhonghua Yi Xue Za Zhi (Taipei); 1990 Jul; 46(1):7-16. PubMed ID: 2176928
[TBL] [Abstract][Full Text] [Related]
7. [Sensitivity test of anti-tumor agents. 2. Application of MTT assay].
Wada Y; Tomiyoshi Y; Fujimaru J; Ogura M; Yoshida S; Takeda Y
Gan To Kagaku Ryoho; 1991 Aug; 18(10):1587-92. PubMed ID: 1908212
[TBL] [Abstract][Full Text] [Related]
8. Chemosensitivity testing of fresh human leukemia cells using both a dye exclusion assay and a tetrazolium dye (MTT) assay.
Kirkpatrick DL; Duke M; Goh TS
Leuk Res; 1990; 14(5):459-66. PubMed ID: 2345469
[TBL] [Abstract][Full Text] [Related]
9. The MTT cell viability assay for cytotoxicity testing in multidrug-resistant human leukemic cells.
Marks DC; Belov L; Davey MW; Davey RA; Kidman AD
Leuk Res; 1992 Dec; 16(12):1165-73. PubMed ID: 1361210
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing.
Carmichael J; DeGraff WG; Gazdar AF; Minna JD; Mitchell JB
Cancer Res; 1987 Feb; 47(4):936-42. PubMed ID: 3802100
[TBL] [Abstract][Full Text] [Related]
11. Comparison of chemosensitivity tests: clonogenic assay versus MTT assay.
Kawada K; Yonei T; Ueoka H; Kiura K; Tabata M; Takigawa N; Harada M; Tanimoto M
Acta Med Okayama; 2002 Jun; 56(3):129-34. PubMed ID: 12108583
[TBL] [Abstract][Full Text] [Related]
12. The MTT assay yields a relatively lower result of growth inhibition than the ATP assay depending on the chemotherapeutic drugs tested.
Ulukaya E; Ozdikicioglu F; Oral AY; Demirci M
Toxicol In Vitro; 2008 Feb; 22(1):232-9. PubMed ID: 17904330
[TBL] [Abstract][Full Text] [Related]
13. [Strategy for therapy of malignant ascites using MTT assay].
Katano M; Oogushi K; Morita H; Sunaga T; Matsunaga H; Yamamoto H; Hisatsugu T
Gan To Kagaku Ryoho; 1992 Jun; 19(6):811-5. PubMed ID: 1605658
[TBL] [Abstract][Full Text] [Related]
14. Histopathologic features of retinoblastoma and its relation with in vitro drug resistance measured by means of the MTT assay.
Schouten-van Meeteren AY; van der Valk P; van der Linden HC; Moll AC; Imhof SM; Huismans DR; Loonen AH; Veerman AJ
Cancer; 2001 Dec; 92(11):2933-40. PubMed ID: 11753969
[TBL] [Abstract][Full Text] [Related]
15. Application of the MTT assay to human prostate cancer cell lines in vitro: establishment of test conditions and assessment of hormone-stimulated growth and drug-induced cytostatic and cytotoxic effects.
Romijn JC; Verkoelen CF; Schroeder FH
Prostate; 1988; 12(1):99-110. PubMed ID: 3126493
[TBL] [Abstract][Full Text] [Related]
16. [A study of MTT-hybrid assay using human bone and soft tissue tumor cells].
Kawai A; Ito S; Ozaki T; Inoue H; Tanabe G; Sato J
Hum Cell; 1989 Sep; 2(3):283-9. PubMed ID: 2519217
[TBL] [Abstract][Full Text] [Related]
17. Interference by anti-cancer chemotherapeutic agents in the MTT-tumor chemosensitivity assay.
Ulukaya E; Colakogullari M; Wood EJ
Chemotherapy; 2004 Apr; 50(1):43-50. PubMed ID: 15084806
[TBL] [Abstract][Full Text] [Related]
18. Chemosensitivity testing of clinical gastrointestinal cancers using histoculture and the MTT end-point.
Furukawa T; Kubota T; Watanabe M; Kase S; Takahara T; Yamaguchi H; Takeuchi T; Teramoto T; Ishibiki K; Kitajima M
Anticancer Res; 1992; 12(5):1377-82. PubMed ID: 1444194
[TBL] [Abstract][Full Text] [Related]
19. A comparison of a CB17 scid mouse model and the tetrazolium-dye assay using human haematological tumour cell lines.
Cattan AR; Maung ZT
Cancer Chemother Pharmacol; 1996; 38(6):548-52. PubMed ID: 8823497
[TBL] [Abstract][Full Text] [Related]
20. In vitro chemosensitivity of lymphoblasts at relapse in childhood leukemia using the MTT assay.
Hongo T; Fujii Y
Int J Hematol; 1991 Jun; 54(3):219-30. PubMed ID: 1747457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
